Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures

PLoS Pathogens

Volumn 11, Issue 12, 2015, Pages

  Johnson, Sara M ^a,b   McNally, Beth A ^a,b,f   Ioannidis, Ioannis ^a,b,g   Flano, Emilio ^a,b,h   Teng, Michael N ^c   Oomens, Antonius G ^d   Walsh, Edward E ^e   Peeples, Mark E ^a,b  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d OKLAHOMA STATE UNIVERSITY   (United States)

^e UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^f PGXL Laboratories   (United States)

^g UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^h Cambridge Discovery Park   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; CX3C CHEMOKINE; GREEN FLUORESCENT PROTEIN; CHEMOKINE RECEPTOR; CX3CR1 PROTEIN, HUMAN; GUANINE NUCLEOTIDE BINDING PROTEIN; VIRAL PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; RESPIRATORY EPITHELIUM; VIRAL GENETICS; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL LINE; GENETIC TRANSFECTION; HOST PARASITE INTERACTION; METABOLISM; PHYSIOLOGY; RESPIRATORY MUCOSA; RESPIRATORY SYNCYTIAL VIRUS INFECTION; VIROLOGY; VIRUS ENTRY;

ANIMALS; CELL LINE; CELLS, CULTURED; GTP-BINDING PROTEINS; HOST-PARASITE INTERACTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; RECEPTORS, CHEMOKINE; RESPIRATORY MUCOSA; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; TRANSFECTION; VIRAL PROTEINS; VIRUS INTERNALIZATION;

EID: 84953298218     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005318     Document Type: Article

References (65)

1. Glezen WP, Taber LH, Frank AL, Kasel JA, (1986) Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 140: 543–546. 3706232
2. Holberg CJ, Wright AL, Martinez FD, Ray CG, Taussig LM, et al. (1991) Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life. Am J Epidemiol 133: 1135–1151. 2035517
3. Langley JM, LeBlanc JC, Smith B, Wang EE, (2003) Increasing incidence of hospitalization for bronchiolitis among Canadian children, 1980–2000. J Infect Dis 188: 1764–1767. 14639549
4. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, et al. (1999) Bronchiolitis-associated hospitalizations among US children, 1980–1996. JAMA 282: 1440–1446. 10535434
5. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, et al. (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2095–2128. doi: 10.1016/S0140-6736(12)61728-0 23245604
6. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, et al. (2010) Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375: 1545–1555. doi: 10.1016/S0140-6736(10)60206-1 20399493
7. Murata Y, Falsey AR, (2007) Respiratory syncytial virus infection in adults. Antivir Ther 12: 659–670. 17944273
8. Falsey AR, Walsh EE, (2000) Respiratory syncytial virus infection in adults. Clin Microbiol Rev 13: 371–384. 10885982
9. Hallak LK, Collins PL, Knudson W, Peeples ME, (2000) Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection. Virology 271: 264–275. 10860881
10. Hallak LK, Kwilas SA, Peeples ME, (2007) Interaction between respiratory syncytial virus and glycosaminoglycans, including heparan sulfate. Methods Mol Biol 379: 15–34. 17502668
11. Krusat T, Streckert HJ, (1997) Heparin-dependent attachment of respiratory syncytial virus (RSV) to host cells. Archives of Virology 142: 1247–1254. 9229012
12. Pickles RJ, McCarty D, Matsui H, Hart PJ, Randell SH, et al. (1998) Limited entry of adenovirus vectors into well-differentiated airway epithelium is responsible for inefficient gene transfer. J Virol 72: 6014–6023. 9621064
13. Zhang L, Bukreyev A, Thompson CI, Watson B, Peeples ME, et al. (2005) Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium. J Virol 79: 1113–1124. 15613339
14. Scull MA, Gillim-Ross L, Santos C, Roberts KL, Bordonali E, et al. (2009) Avian Influenza virus glycoproteins restrict virus replication and spread through human airway epithelium at temperatures of the proximal airways. PLoS Pathog 5: e1000424. doi: 10.1371/journal.ppat.1000424 19436701
15. Schaap-Nutt A, Scull MA, Schmidt AC, Murphy BR, Pickles RJ, (2010) Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys. Vaccine 28: 2788–2798. doi: 10.1016/j.vaccine.2010.01.050 20139039
16. Sims AC, Baric RS, Yount B, Burkett SE, Collins PL, et al. (2005) Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs. J Virol 79: 15511–15524. 16306622
17. Villenave R, Thavagnanam S, Sarlang S, Parker J, Douglas I, et al. (2012) In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo. Proc Natl Acad Sci U S A 109: 5040–5045. doi: 10.1073/pnas.1110203109 22411804
18. Bartlett EJ, Hennessey M, Skiadopoulos MH, Schmidt AC, Collins PL, et al. (2008) Role of interferon in the replication of human parainfluenza virus type 1 wild type and mutant viruses in human ciliated airway epithelium. J Virol 82: 8059–8070. doi: 10.1128/JVI.02263-07 18524813
19. Zhang L, Peeples ME, Boucher RC, Collins PL, Pickles RJ, (2002) Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J Virol 76: 5654–5666. 11991994
20. Barr FE, Pedigo H, Johnson TR, Shepherd VL, (2000) Surfactant protein-A enhances uptake of respiratory syncytial virus by monocytes and U937 macrophages. Am J Respir Cell Mol Biol 23: 586–592. 11062136
21. Hickling TP, Malhotra R, Bright H, McDowell W, Blair ED, et al. (2000) Lung surfactant protein A provides a route of entry for respiratory syncytial virus into host cells. Viral Immunol 13: 125–135. 10733174
22. Malhotra R, Ward M, Bright H, Priest R, Foster MR, et al. (2003) Isolation and characterisation of potential respiratory syncytial virus receptor(s) on epithelial cells. Microbes Infect 5: 123–133. 12650770
23. Tripp RA, Jones LP, Haynes LM, Zheng H, Murphy PM, et al. (2001) CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat Immunol 2: 732–738. 11477410
24. Kwilas S, Liesman RM, Zhang L, Walsh E, Pickles RJ, et al. (2009) Respiratory syncytial virus grown in Vero cells contains a truncated attachment protein that alters its infectivity and dependence on glycosaminoglycans. J Virol 83: 10710–10718. doi: 10.1128/JVI.00986-09 19656891
25. Behera AK, Matsuse H, Kumar M, Kong X, Lockey RF, et al. (2001) Blocking intercellular adhesion molecule-1 on human epithelial cells decreases respiratory syncytial virus infection. Biochem Biophys Res Commun 280: 188–195. 11162498
26. Haynes LM, Moore DD, Kurt-Jones EA, Finberg RW, Anderson LJ, et al. (2001) Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J Virol 75: 10730–10737. 11602714
27. Tayyari F, Marchant D, Moraes TJ, Duan W, Mastrangelo P, et al. (2011) Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat Med 17: 1132–1135. doi: 10.1038/nm.2444 21841784
28. Hallak LK, Spillmann D, Collins PL, Peeples ME, (2000) Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. J Virol 74: 10508–10513. 11044095
29. Techaarpornkul S, Collins PL, Peeples ME, (2002) Respiratory syncytial virus with the fusion protein as its only viral glycoprotein is less dependent on cellular glycosaminoglycans for attachment than complete virus. Virology 294: 296–304. 12009871
30. Walsh EE, Falsey AR, Sullender WM, (1998) Monoclonal antibody neutralization escape mutants of respiratory syncytial virus with unique alterations in the attachment (G) protein. J Gen Virol 79 (Pt 3): 479–487. 9519826
31. Teng MN, Collins PL, (2002) The central conserved cystine noose of the attachment G protein of human respiratory syncytial virus is not required for efficient viral infection in vitro or in vivo. Journal of Virology 76: 6164–6171. 12021350
32. Mitra R, Baviskar P, Duncan-Decocq RR, Patel D, Oomens AG, (2012) The human respiratory syncytial virus matrix protein is required for maturation of viral filaments. J Virol 86: 4432–4443. doi: 10.1128/JVI.06744-11 22318136
33. Esko JD, Stewart TE, Taylor WH, (1985) Animal cell mutants defective in glycosaminoglycan biosynthesis. Proc Natl Acad Sci U S A 82: 3197–3201. 3858816
34. Fulcher ML, Gabriel S, Burns KA, Yankaskas JR, Randell SH, (2005) Well-differentiated human airway epithelial cell cultures. Methods Mol Med 107: 183–206. 15492373
35. Walsh EE, Hruska J, (1983) Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion protein. J Virol 47: 171–177. 6345804
36. Anderson LJ, Bingham P, Hierholzer JC, (1988) Neutralization of respiratory syncytial virus by individual and mixtures of F and G protein monoclonal antibodies. J Virol 62: 4232–4238. 2459412
37. Jung S, Aliberti J, Graemmel P, Sunshine MJ, Kreutzberg GW, et al. (2000) Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 20: 4106–4114. 10805752
38. Walsh EE, Hall CB, Schlesinger JJ, Brandriss MW, Hildreth S, et al. (1989) Comparison of antigenic sites of subtype-specific respiratory syncytial virus attachment proteins. J Gen Virol 70 (Pt 11): 2953–2961. 2479715
39. Tatsuo H, Ono N, Tanaka K, Yanagi Y, (2000) SLAM (CDw150) is a cellular receptor for measles virus. Nature 406: 893–897. 10972291
40. Palmer SG, DeVito I, Jenkins SG, Niewiesk S, Porotto M, et al. (2014) Circulating clinical strains of human parainfluenza virus reveal viral entry requirements for in vivo infection. J Virol 88: 13495–13502. doi: 10.1128/JVI.01965-14 25210187
41. Stokes KL, Chi MH, Sakamoto K, Newcomb DC, Currier MG, et al. (2011) Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice. J Virol 85: 5782–5793. doi: 10.1128/JVI.01693-10 21471228
42. Wertz GW, Collins PL, Huang Y, Gruber C, Levine S, et al. (1985) Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein. Proc Natl Acad Sci U S A 82: 4075–4079. 3858865
43. Satake M, Coligan JE, Elango N, Norrby E, Venkatesan S, (1985) Respiratory syncytial virus envelope glycoprotein (G) has a novel structure. Nucleic Acids Res 13: 7795–7812. 4069997
44. Gorman JJ, Ferguson BL, Speelman D, Mills J, (1997) Determination of the disulfide bond arrangement of human respiratory syncytial virus attachment (G) protein by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Protein Sci 6: 1308–1315. 9194191
45. Feldman SA, Hendry RM, Beeler JA, (1999) Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G. J Virol 73: 6610–6617. 10400758
46. Sullender W, (1995) Antigenic analysis of chimeric and truncated G proteins of respiratory syncytial virus. Virology 209: 70–79. 7747486
47. Jamieson WL, Shimizu S, D'Ambrosio JA, Meucci O, Fatatis A, (2008) CX3CR1 is expressed by prostate epithelial cells and androgens regulate the levels of CX3CL1/fractalkine in the bone marrow: potential role in prostate cancer bone tropism. Cancer Res 68: 1715–1722. doi: 10.1158/0008-5472.CAN-07-1315 18339851
48. Harrison JK, Jiang Y, Chen S, Xia Y, Maciejewski D, et al. (1998) Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci U S A 95: 10896–10901. 9724801
49. Perros F, Dorfmuller P, Souza R, Durand-Gasselin I, Godot V, et al. (2007) Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension. Eur Respir J 29: 937–943. 17182651
50. Bar-On L, Birnberg T, Lewis KL, Edelson BT, Bruder D, et al. (2010) CX3CR1+ CD8alpha+ dendritic cells are a steady-state population related to plasmacytoid dendritic cells. Proc Natl Acad Sci U S A 107: 14745–14750. doi: 10.1073/pnas.1001562107 20679228
51. Imai T, Hieshima K, Haskell C, Baba M, Nagira M, et al. (1997) Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91: 521–530. 9390561
52. Nishimura M, Umehara H, Nakayama T, Yoneda O, Hieshima K, et al. (2002) Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J Immunol 168: 6173–6180. 12055230
53. Meucci O, Fatatis A, Simen AA, Miller RJ, (2000) Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc Natl Acad Sci U S A 97: 8075–8080. 10869418
54. Dyer KD, Percopo CM, Fischer ER, Gabryszewski SJ, Rosenberg HF, (2009) Pneumoviruses infect eosinophils and elicit MyD88-dependent release of chemoattractant cytokines and interleukin-6. Blood 114: 2649–2656. doi: 10.1182/blood-2009-01-199497 19652202
55. Li XQ, Fu ZF, Alvarez R, Henderson C, Tripp RA, (2006) Respiratory syncytial virus (RSV) infects neuronal cells and processes that innervate the lung by a process involving RSV G protein. J Virol 80: 537–540. 16352577
56. Jeong KI, Piepenhagen PA, Kishko M, DiNapoli JM, Groppo RP, et al. (2015) CX3CR1 Is Expressed in Differentiated Human Ciliated Airway Cells and Co-Localizes with Respiratory Syncytial Virus on Cilia in a G Protein-Dependent Manner. PLoS One 10: e0130517. doi: 10.1371/journal.pone.0130517 26107373
57. Dorig RE, Marcil A, Chopra A, Richardson CD, (1993) The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75: 295–305. 8402913
58. Zhang W, Choi Y, Haynes LM, Harcourt JL, Anderson LJ, et al. (2010) Vaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice. J Virol 84: 1148–1157. doi: 10.1128/JVI.01755-09 19864390
59. Haynes LM, Caidi H, Radu GU, Miao C, Harcourt JL, et al. (2009) Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB/c mice. J Infect Dis 200: 439–447. doi: 10.1086/600108 19545210
60. Johnson CH, Miao C, Blanchard EG, Caidi H, Radu GU, et al. (2012) Effect of chemokine receptor CX3CR1 deficiency in a murine model of respiratory syncytial virus infection. Comp Med 62: 14–20. 22330646
61. Graham BS, Bunton LA, Wright PF, Karzon DT, (1991) Reinfection of mice with respiratory syncytial virus. J Med Virol 34: 7–13. 1885946
62. Shinoff JJ, O'Brien KL, Thumar B, Shaw JB, Reid R, et al. (2008) Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus. Journal of Infectious Diseases 198: 1007–1015. doi: 10.1086/591460 18702606
63. Kim S, Joo DH, Lee JB, Shim BS, Cheon IS, et al. (2012) Dual role of respiratory syncytial virus glycoprotein fragment as a mucosal immunogen and chemotactic adjuvant. PLoS One 7: e32226. doi: 10.1371/journal.pone.0032226 22384186
64. Nguyen TN, Power UF, Robert A, Haeuw JF, Helffer K, et al. (2012) The respiratory syncytial virus G protein conserved domain induces a persistent and protective antibody response in rodents. PLoS One 7: e34331. doi: 10.1371/journal.pone.0034331 22479601
65. Choi Y, Mason CS, Jones LP, Crabtree J, Jorquera PA, et al. (2012) Antibodies to the central conserved region of respiratory syncytial virus (RSV) G protein block RSV G protein CX3C-CX3CR1 binding and cross-neutralize RSV A and B strains. Viral Immunol 25: 193–203. doi: 10.1089/vim.2011.0094 22551066